Company news
Daiichi Sankyo Company, Limited news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
IDeate-Esophageal01 Phase 3 Trial of Ifinatamab Deruxtecan Initiated in Certain Patients with Pretreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma
May 19, 2025
ENHERTU® Followed by THP Before Surgery Showed Statistically Significant and Clinically Meaningful Improvement in Pathologic Complete Response in Patients With High-Risk HER2 Positive Early-Stage Breast Cancer in DESTINY-Breast11 Phase 3 Trial
May 7, 2025
Calls
The 5 newest of 13 calls. Every call is listed under its year.
- Daiichi Sankyo (Tokyo:4568) Q1 2026 Earnings Call
Jul 31, 2026
Transcript - Daiichi Sankyo (Tokyo:4568) Q4 2025 Earnings Call
May 11, 2026
Transcript - Daiichi Sankyo (Tokyo:4568) Q3 2025 Earnings Call
Dec 30, 2025
Transcript - Daiichi Sankyo (Tokyo:4568) Q2 2025 Earnings Call
Oct 31, 2025
Transcript - Daiichi Sankyo (Tokyo:4568) Q1 2025 Earnings Call
Jul 31, 2025
Transcript
Decks
The 5 newest of 133 decks. Every deck is listed under its year.
- Q2 2026 Earnings Presentation
Earnings · 40 slides · Oct 30, 2026
- Q2 FY2026 Earnings Presentation
Earnings · 40 slides · Oct 30, 2026
- Q1 FY2026 Earnings Presentation
Earnings · 38 slides · Jul 31, 2026
- Q1 FY2026 Earnings Presentation
Earnings · 38 slides · Jul 31, 2026
- FY2025 Earnings Presentation
Earnings · 80 slides · May 11, 2026